Sagar Life Sciences Private Limited
Sagar Life Sciences Private Limited is a Private Non-govt company company incorporated in 2007 and based in Gujarat, India. Sagar Life Sciences Private Limited operates in Chemical preparations of a kind used in textile / paper / leather industry, manu (NIC 24297) with authorized capital of ₹3.00 Cr and paid-up capital of ₹1.75 Cr. For 2021-22, the company reported revenue of ₹57.22 Cr and profit after tax of ₹2.80 Cr. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +7d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Sagar Life Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 355356303 | HDFC Bank Ltd(Bank) | ₹22.48 Cr | 19 Sep 2021 | Open |
| 607334415 | HDFC Bank Ltd(Bank) | ₹2.47 Cr | 04 Jul 2022 | Satisfied |
| 703702568 | ICICI Bank Ltd(Bank) | ₹23.15 Cr | 04 Jul 2021 | Open |
| 313461067 | Axis Bank Ltd(Bank) | ₹10.60 Cr | 12 Mar 2023 | Open |
| 307289715 | Axis Bank Ltd(Bank) | ₹4.46 Cr | 27 Jan 2020 | Open |
Charge IDs, lenders & amounts for Sagar Life Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
4 FYs| Line item | 2021-22 | 2020-21 | 2018-19 | 2017-18 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2021-22 | +22.0% | +86.0% | — | |
| Profit after Tax2021-22 | +305.0% | +765.0% | — | |
| Net Worth2021-22 | +86.0% | +38.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | +0.16% | — | +0.67% | +0.16% | 4.26 | |||
| 2017-18 | +1.35% | +65.71% | +8.75% | +1.89% | 4.62 | |||
| 2018-19 | +3.31% | +41.35% | +23.05% | +3.84% | 6.00 | |||
| 2020-21 | +2.81% | +51.22% | +21.53% | +3.54% | 6.07 | |||
| 2021-22 | +4.89% | +54.45% | +35.96% | +6.99% | 5.14 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,02,08,738 | 79.65% |
| Institutional Investors | 2 | 7,74,619 | 3.05% |
| Public & Others | 43 | 43,87,903 | 17.29% |
Promoter, institutional & public holding for Sagar Life Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
136 peersTop 10 in Chemical preparations of a kind used in textile / paper / leather industry, manu
by healthView all ›Events & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.